Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3818041rdf:typepubmed:Citationlld:pubmed
pubmed-article:3818041lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:3818041lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:3818041pubmed:issue2lld:pubmed
pubmed-article:3818041pubmed:dateCreated1987-3-31lld:pubmed
pubmed-article:3818041pubmed:abstractTextThe effect of verapamil on pressor response to Angiotensin II (A II) was investigated in rats. The responses to A II (10, 20, 40 ng, iv) was reduced after verapamil (50 and 100 micrograms, iv per rat) in a dose dependent manner. Treatment for 5 day with verapamil (18 mg/100 g/day, po) let to some reduction in basal blood pressure but pressor response to A II was not changed. Treatment for 20 days significantly reduced the basal blood pressure and increased the responsiveness to A II. it is concluded that Ca++ plays a major role in the pressor responses to A II and that chronic treatment with verapamil may reduce basal blood pressure.lld:pubmed
pubmed-article:3818041pubmed:languageenglld:pubmed
pubmed-article:3818041pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818041pubmed:citationSubsetIMlld:pubmed
pubmed-article:3818041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3818041pubmed:statusMEDLINElld:pubmed
pubmed-article:3818041pubmed:issn0019-5499lld:pubmed
pubmed-article:3818041pubmed:authorpubmed-author:LallS BSBlld:pubmed
pubmed-article:3818041pubmed:authorpubmed-author:RajdevSSlld:pubmed
pubmed-article:3818041pubmed:authorpubmed-author:GuptaY KYKlld:pubmed
pubmed-article:3818041pubmed:authorpubmed-author:KheterpalKKlld:pubmed
pubmed-article:3818041pubmed:issnTypePrintlld:pubmed
pubmed-article:3818041pubmed:volume30lld:pubmed
pubmed-article:3818041pubmed:ownerNLMlld:pubmed
pubmed-article:3818041pubmed:authorsCompleteYlld:pubmed
pubmed-article:3818041pubmed:pagination145-8lld:pubmed
pubmed-article:3818041pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:meshHeadingpubmed-meshheading:3818041-...lld:pubmed
pubmed-article:3818041pubmed:articleTitleThe effect of acute and chronic treatment of verapamil on pressor response to angiotensin II in rats.lld:pubmed
pubmed-article:3818041pubmed:publicationTypeJournal Articlelld:pubmed